Zverev K V, Kutyrina I M, Gersimenko O I
Klin Med (Mosk). 1995;73(3):99-102.
Patients at risk to develop intraglomerular hypertension were denoted among those with chronic glomerulonephritis (CGN) basing on the relationships between various clinico-laboratory findings, clinical syndromes and markers of intraglomerular hypertension (low or absent renal functional reserve). The risk groups include CGN patients with urinary syndrome and arterial hypertension with nephrotic disease and serum creatinine over 1.4 mg/%, with renal damage typical for focal-segmental glomerulosclerosis or fibroplastic glomerulonephritis. Patients with nonimmune progression via a rise of intraglomerular pressure should be given drugs reducing intraglomerular hypertension.
根据各种临床实验室检查结果、临床综合征与肾小球内高血压标志物(肾功能储备低下或缺乏)之间的关系,在慢性肾小球肾炎(CGN)患者中确定有发生肾小球内高血压风险的患者。风险组包括患有尿综合征和动脉高血压且伴有肾病以及血清肌酐超过1.4mg/%的CGN患者,伴有局灶节段性肾小球硬化或纤维增生性肾小球肾炎典型的肾损害。对于因肾小球内压力升高而出现非免疫性进展的患者,应给予降低肾小球内高血压的药物。